108 related articles for article (PubMed ID: 14688482)
1. Caspase 10 levels are increased following DNA damage in a p53-dependent manner.
Rikhof B; Corn PG; El-Deiry WS
Cancer Biol Ther; 2003; 2(6):707-12. PubMed ID: 14688482
[TBL] [Abstract][Full Text] [Related]
2. p53-dependent activation of microRNA-34a in response to etoposide-induced DNA damage in osteosarcoma cell lines not impaired by dominant negative p53 expression.
Novello C; Pazzaglia L; Conti A; Quattrini I; Pollino S; Perego P; Picci P; Benassi MS
PLoS One; 2014; 9(12):e114757. PubMed ID: 25490093
[TBL] [Abstract][Full Text] [Related]
3. AMPK-beta1 subunit is a p53-independent stress responsive protein that inhibits tumor cell growth upon forced expression.
Li J; Jiang P; Robinson M; Lawrence TS; Sun Y
Carcinogenesis; 2003 May; 24(5):827-34. PubMed ID: 12771025
[TBL] [Abstract][Full Text] [Related]
4. Apoptotic threshold is lowered by p53 transactivation of caspase-6.
MacLachlan TK; El-Deiry WS
Proc Natl Acad Sci U S A; 2002 Jul; 99(14):9492-7. PubMed ID: 12089322
[TBL] [Abstract][Full Text] [Related]
5. Caspase 9 is required for p53-dependent apoptosis and chemosensitivity in a human ovarian cancer cell line.
Wu GS; Ding Z
Oncogene; 2002 Jan; 21(1):1-8. PubMed ID: 11791171
[TBL] [Abstract][Full Text] [Related]
6. ECRG2, a novel transcriptional target of p53, modulates cancer cell sensitivity to DNA damage.
Patel H; Sheikh MS; Huang Y
Cell Death Dis; 2020 Jul; 11(7):543. PubMed ID: 32681017
[TBL] [Abstract][Full Text] [Related]
7. Requirement of p53 targets in chemosensitization of colonic carcinoma to death ligand therapy.
Wang S; El-Deiry WS
Proc Natl Acad Sci U S A; 2003 Dec; 100(25):15095-100. PubMed ID: 14645705
[TBL] [Abstract][Full Text] [Related]
8. 5-Lipoxygenase is a direct p53 target gene in humans.
Gilbert B; Ahmad K; Roos J; Lehmann C; Chiba T; Ulrich-Rückert S; Smeenk L; van Heeringen S; Maier TJ; Groner B; Steinhilber D
Biochim Biophys Acta; 2015 Aug; 1849(8):1003-16. PubMed ID: 26070487
[TBL] [Abstract][Full Text] [Related]
9. Microarray analysis of p53-dependent gene expression in response to hypoxia and DNA damage.
Corn PG; El-Deiry WS
Cancer Biol Ther; 2007 Dec; 6(12):1858-66. PubMed ID: 18087215
[TBL] [Abstract][Full Text] [Related]
10. A comprehensive assessment of p53-responsive genes following adenoviral-p53 gene transfer in Bcl-2-expressing prostate cancer cells.
Spurgers KB; Coombes KR; Meyn RE; Gold DL; Logothetis CJ; Johnson TJ; McDonnell TJ
Oncogene; 2004 Mar; 23(9):1712-23. PubMed ID: 14647426
[TBL] [Abstract][Full Text] [Related]
11. Suppression of Polo like kinase 1 (PLK1) by p21(Waf1) mediates the p53-dependent prevention of caspase-independent mitotic death.
Lin YC; Sun SH; Wang FF
Cell Signal; 2011 Nov; 23(11):1816-23. PubMed ID: 21726628
[TBL] [Abstract][Full Text] [Related]
12. Transcriptional activation of caspase-6 and -7 genes by cisplatin-induced p53 and its functional significance in cisplatin nephrotoxicity.
Yang C; Kaushal V; Haun RS; Seth R; Shah SV; Kaushal GP
Cell Death Differ; 2008 Mar; 15(3):530-44. PubMed ID: 18064040
[TBL] [Abstract][Full Text] [Related]
13. Identification of a caspase-2 isoform that behaves as an endogenous inhibitor of the caspase cascade.
Droin N; Beauchemin M; Solary E; Bertrand R
Cancer Res; 2000 Dec; 60(24):7039-47. PubMed ID: 11156409
[TBL] [Abstract][Full Text] [Related]
14. Evidence that the death receptor DR4 is a DNA damage-inducible, p53-regulated gene.
Guan B; Yue P; Clayman GL; Sun SY
J Cell Physiol; 2001 Jul; 188(1):98-105. PubMed ID: 11382926
[TBL] [Abstract][Full Text] [Related]
15. Interferonalpha enhances etoposide-induced apoptosis in human osteosarcoma U2OS cells by a p53-dependent pathway.
Yuan XW; Zhu XF; Liang SG; Fan Q; Chen ZX; Huang XF; Sheng PY; He AS; Yang ZB; Deng R; Feng GK; Liao WM
Life Sci; 2008 Feb; 82(7-8):393-401. PubMed ID: 18191951
[TBL] [Abstract][Full Text] [Related]
16. Decoy receptor 2 (DcR2) is a p53 target gene and regulates chemosensitivity.
Liu X; Yue P; Khuri FR; Sun SY
Cancer Res; 2005 Oct; 65(20):9169-75. PubMed ID: 16230375
[TBL] [Abstract][Full Text] [Related]
17. Human survivin is negatively regulated by wild-type p53 and participates in p53-dependent apoptotic pathway.
Mirza A; McGuirk M; Hockenberry TN; Wu Q; Ashar H; Black S; Wen SF; Wang L; Kirschmeier P; Bishop WR; Nielsen LL; Pickett CB; Liu S
Oncogene; 2002 Apr; 21(17):2613-22. PubMed ID: 11965534
[TBL] [Abstract][Full Text] [Related]
18. Interferon-gamma-induced sensitization of colon carcinomas to ZD9331 targets caspases, downstream of Fas, independent of mitochondrial signaling and the inhibitor of apoptosis survivin.
Geller J; Petak I; Szucs KS; Nagy K; Tillman DM; Houghton JA
Clin Cancer Res; 2003 Dec; 9(17):6504-15. PubMed ID: 14695155
[TBL] [Abstract][Full Text] [Related]
19. Etoposide (VP-16) sensitizes p53-deficient human non-small cell lung cancer cells to caspase-7-mediated apoptosis.
Chiu CC; Lin CH; Fang K
Apoptosis; 2005 May; 10(3):643-50. PubMed ID: 15909125
[TBL] [Abstract][Full Text] [Related]
20. Lack of p53 augments thymoquinone-induced apoptosis and caspase activation in human osteosarcoma cells.
Roepke M; Diestel A; Bajbouj K; Walluscheck D; Schonfeld P; Roessner A; Schneider-Stock R; Gali-Muhtasib H
Cancer Biol Ther; 2007 Feb; 6(2):160-9. PubMed ID: 17218778
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
